Cooper Investors PTY Ltd. increased its position in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) by 1.5% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 358,925 shares of the company's stock after buying an additional 5,272 shares during the quarter. Ryan Specialty comprises approximately 4.3% of Cooper Investors PTY Ltd.'s portfolio, making the stock its 6th largest position. Cooper Investors PTY Ltd. owned about 0.14% of Ryan Specialty worth $26,514,000 at the end of the most recent quarter.
A number of other large investors have also recently added to or reduced their stakes in the business. Mariner LLC boosted its position in shares of Ryan Specialty by 3.4% during the 4th quarter. Mariner LLC now owns 5,278 shares of the company's stock worth $339,000 after purchasing an additional 172 shares during the period. Sanctuary Advisors LLC lifted its stake in Ryan Specialty by 1.2% during the fourth quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company's stock worth $1,045,000 after purchasing an additional 188 shares in the last quarter. CIBC Asset Management Inc boosted its position in shares of Ryan Specialty by 5.6% during the fourth quarter. CIBC Asset Management Inc now owns 3,674 shares of the company's stock worth $236,000 after buying an additional 196 shares during the period. UMB Bank n.a. grew its stake in shares of Ryan Specialty by 5.0% in the first quarter. UMB Bank n.a. now owns 5,797 shares of the company's stock valued at $428,000 after buying an additional 275 shares in the last quarter. Finally, Treasurer of the State of North Carolina raised its holdings in shares of Ryan Specialty by 0.6% in the 4th quarter. Treasurer of the State of North Carolina now owns 44,990 shares of the company's stock valued at $2,887,000 after buying an additional 280 shares during the period. 84.82% of the stock is currently owned by institutional investors and hedge funds.
Ryan Specialty Stock Up 0.7%
Ryan Specialty stock traded up $0.50 during midday trading on Friday, reaching $67.73. The company's stock had a trading volume of 1,317,332 shares, compared to its average volume of 919,679. The company has a market cap of $17.77 billion, a P/E ratio of 199.20, a P/E/G ratio of 1.79 and a beta of 0.70. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 3.45. The business has a 50-day simple moving average of $68.28 and a 200-day simple moving average of $68.07. Ryan Specialty Holdings Inc. has a fifty-two week low of $55.67 and a fifty-two week high of $77.16.
Ryan Specialty (NYSE:RYAN - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The company reported $0.39 EPS for the quarter, meeting analysts' consensus estimates of $0.39. The business had revenue of $690.17 million for the quarter, compared to the consensus estimate of $680.80 million. Ryan Specialty had a return on equity of 47.70% and a net margin of 6.97%. The business's revenue for the quarter was up 25.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.35 EPS. On average, research analysts expect that Ryan Specialty Holdings Inc. will post 2.29 earnings per share for the current fiscal year.
Ryan Specialty Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th were issued a dividend of $0.12 per share. The ex-dividend date of this dividend was Tuesday, May 13th. This represents a $0.48 dividend on an annualized basis and a yield of 0.71%. Ryan Specialty's payout ratio is currently 141.18%.
Wall Street Analysts Forecast Growth
A number of equities analysts recently commented on the company. The Goldman Sachs Group upgraded Ryan Specialty from a "neutral" rating to a "buy" rating and raised their target price for the company from $74.00 to $81.00 in a report on Tuesday, May 13th. Keefe, Bruyette & Woods dropped their price target on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a research note on Wednesday, April 9th. Morgan Stanley upped their price objective on Ryan Specialty from $78.00 to $80.00 and gave the stock an "overweight" rating in a research report on Monday, May 19th. Wells Fargo & Company reduced their price objective on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 10th. Finally, Barclays cut their price target on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating on the stock in a report on Friday, April 11th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $75.58.
Read Our Latest Research Report on Ryan Specialty
Insiders Place Their Bets
In other news, EVP Mark Stephen Katz sold 14,377 shares of Ryan Specialty stock in a transaction dated Friday, June 13th. The stock was sold at an average price of $65.84, for a total transaction of $946,581.68. Following the sale, the executive vice president now owns 1,117 shares in the company, valued at approximately $73,543.28. The trade was a 92.79% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director David P. Bolger sold 5,000 shares of the company's stock in a transaction dated Tuesday, June 3rd. The shares were sold at an average price of $70.80, for a total value of $354,000.00. Following the completion of the sale, the director now directly owns 71,467 shares of the company's stock, valued at approximately $5,059,863.60. This trade represents a 6.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. 52.21% of the stock is owned by corporate insiders.
Ryan Specialty Company Profile
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Recommended Stories

Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.